That partnership network is reasonably high-profile, and I’m sure they are aiming to get more. Additionally, if I have understood correctly, Aiforia has the most comprehensive AI model portfolio for different types of cancer, and the intention is to expand that as well. It’s difficult for a layman like me to understand how much “mammon” (profit) accumulates from various partnership arrangements, but to my eye, the brisk growth in activity within the industry has been noticeable. Recent news suggests that now is the time to strike while the iron is hot; how successful they will be is another matter. Personally, I’ll only be adding more if I happen to come across some extra cash; my own average price is currently somewhere between 1.90 and 1.92.
5 Likes